Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, 200032, China.
Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, 200032, China.
Theranostics. 2019 Jul 9;9(16):4779-4794. doi: 10.7150/thno.32543. eCollection 2019.
Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi)RNAs and NK cells in progression of hepatocellular carcinoma (HCC). : Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain- and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays and . In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. : Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain- and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration . Bioinformatics and chemokine expression profiling identified chemokine (C-X-C motif) ligand 1 (CXCL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CXCL1-dependent regulation of CXCR1 NK cell infiltration and function. CXCR1 NK cells demonstrated stronger anti-metastatic activity relative to CXCR1 NK cells. CXCL1 stimulated chemotactic migration and cytotoxicity in CXCR1 NK cells via STAT3 signaling. Blockade of CXCL1, CXCR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CXCL1 and CXCR1 NK cells. High miR-561-5p abundance, low CXCL1 levels, and low numbers of CXCR1 NK cells were associated with adverse prognosis. : We delineated a miR-561-5p/CX3CL1/NK cell axis that drives HCC metastasis and demonstrated that CXCR1 NK cells serve as potent antitumor therapeutic effectors.
自然杀伤 (NK) 细胞可以抑制肿瘤的发生和调节转移的扩散,作为先天免疫反应的关键介质。调节 NK 细胞浸润及其抗癌活性的内在因素仍知之甚少。我们研究了 miRNA 失调和 NK 细胞在肝细胞癌 (HCC) 进展中的作用。
使用小 RNA 测序检测 HCC 患者(n=14)或无(n=13)肺转移以及具有不同肺转移潜力的 HCC 细胞系肿瘤组织的 miRNA 图谱。趋化因子表达谱和生物信息学用于检测候选靶标的下游靶标。在增益和功能丧失测定中,用于研究 miRNA 在 HCC 进展中的作用。分离不同亚群的 NK 细胞,用于趋化和功能测定。进行原位杂交和免疫组织化学分析,以检测 2010 年接受根治性切除的 242 名 HCC 患者肿瘤组织中 miRNA 的表达。
三种 miRNA(miR-137、miR-149-5p 和 miR-561-5p)被鉴定为与 HCC 患者的肺转移相关。miR-561-5p 在转移性 HCC 组织和高转移性潜能 HCC 细胞系中表达最高。在小鼠模型中的增益和功能丧失测定中,miR-561-5p 促进肿瘤生长并扩散到肺部。然而,miR-561-5p 似乎不影响细胞增殖和迁移。生物信息学和趋化因子表达谱鉴定趋化因子 (C-X-C 基序) 配体 1 (CXCL1) 为 miR-561-5p 的潜在靶标。此外,miR-561-5p 通过 CXCL1 依赖调节 CXCR1 NK 细胞浸润和功能促进肿瘤发生和转移。与 CXCR1 NK 细胞相比,CXCR1 NK 细胞表现出更强的抗转移活性。CXCL1 通过 STAT3 信号通路刺激 CXCR1 NK 细胞的趋化迁移和细胞毒性。阻断 CXCL1、CXCR1 或 pSTAT3 信号通路可减弱抗肿瘤反应。临床样本显示 miR-561-5p 表达与 CXCL1 和 CXCR1 NK 细胞水平之间呈负相关。高 miR-561-5p 丰度、低 CXCL1 水平和低 CXCR1 NK 细胞数量与不良预后相关。
我们描绘了一个 miR-561-5p/CX3CL1/NK 细胞轴,它驱动 HCC 转移,并证明 CXCR1 NK 细胞作为有效的抗肿瘤治疗效应物。